Editor’s note: The archived video recording is embedded below.
The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed.
Join STAT for a three-part digital event series. Part 2, “Fighting on multiple fronts,” is today. The first part on April 8 discussed antibody drugs that target the coronavirus.
Part 2: Fighting on multiple fronts. April 29 at 1 p.m. EST
- Sponsor introduction: Richard Moscicki, M.D., chief medical officer and executive vice president of science and regulatory advocacy, PhRMA
- Mikael Dolsten, M.D., Ph.D., chief scientific officer, Pfizer
- Matthew Herper, senior writer, medicine, and editorial director of events, STAT